2008-02-19 07:11
(edited by Ohlbe on 2008-02-19 21:46)

Posting: # 1621
Views: 2,360

 Type of studies etc. [Dissolution / BCS / IVIVC]

Dear all,
Anybody let me know about flow for in-vitro studies, In which stage of drug designing we have to take approval for in-vitro studies for both innovative & generic drugs.
Which parameters we have to do?
Do we conduct in-vitro studies separately with different mechanism (different in-vitro parameters) for generic & innovative drugs.
What are the common parameters for generic & innovative drugs (in in-vitro studies)
pz share any guidelines regarding this.

Edit: Category changed. [Ohlbe]
Edit: Subject line altered. [Helmut]
 Admin contact
20,241 posts in 4,259 threads, 1,395 registered users;
online 10 (0 registered, 10 guests [including 5 identified bots]).
Forum time (Europe/Vienna): 16:17 CET

There are no routine statistical questions,
only questionable statistical routines.    David R. Cox

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz